Assessing the Utility of Recruitment Strategies for Preclinical Alzheimer’s Disease Trials Among Racial and Ethnic Groups
Strategies such as providing transportation, risk estimates for developing AD dementia, cognitive test results, and higher monetary compensation all were associated with greater willingness to participate in AD clinical trials overall, but demonstrated few differences in magnitude among ethnic and racial groups.
Authors
- Michelle Nuño
- M. Nishida (ORCID: https://orcid.org/0009-0007-8676-9361)
- Kristin Harkins (ORCID: https://orcid.org/0000-0001-5360-1043)
- Megan Witbracht (ORCID: https://orcid.org/0009-0003-0307-3184)
- Crystal M. Glover (ORCID: https://orcid.org/0000-0002-1430-7463)
- Joshua D. Grill (ORCID: https://orcid.org/0000-0002-4215-7589)
- Daniel L Gillen
- Jason Karlawish
Institutions
- University of Southern California (US)
- University of California, Irvine (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_100590
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00